HBM HEALTHCARE INVESTMENTS AG Key Figures (NAV, Net Assets,
Net Result for the Period) as at 30.6.2015
Zug, 1 July 2015
HBM Healthcare Investments NAV Key Figures as at 30.6.2015*
Net Asset Value (NAV): CHF 129.00 per share (-0.9% vs. 15 June 2015) Net Assets: CHF 991 million
Net result for the period (1.4.2015-30.6.2015):
Net loss CHF 46 million (previous year: net profit CHF 48 million)
* factoring in the cash dividend of CHF 5.50 per registered share as approved by the Shareholders' Meeting on 26 June 2015.
These figures are preliminary results, based on the current status of the closing process. The
Quarterly Report June 2015 will be published on 31 July 2015.
For further information, please contact Dr. Andreas Wicki, tel.: +41 41 768 11 08, andreas.wicki@hbmhealthcare.com
Information on HBM Healthcare Investments Ltd
HBM Healthcare Investments actively invests in the human medicine, biotechnology, medical technology and diagnostics sectors, and related areas. The company holds and manages an international portfolio of some twenty five promising companies. Many of these companies have their lead products already available on the market or at an advanced stage of development. The focus of investment is on follow-on financing for existing portfolio companies. These portfolio companies are closely tracked and actively guided on their strategic directions. This is what makes HBM Healthcare Investments an interesting alternative to investing in big pharma and biotech companies. HBM Healthcare Investments has an international shareholder base and is listed on SIX Swiss Exchange (ticker: HBMN).
Disclaimer
HBM Healthcare Investments AGBundesplatz 1 CH-6300 Zug | Tel: +41 41 768 11 08 | Fax: +41 41 768 11 09 | info@hbmhealthcare.com www.hbmhealthcare.com
NOT FOR DISTRIBUTION IN THE USA, CANADA, JAPAN OR AUSTRALIAThis media release does not constitute an issue prospectus within the meaning of Art. 652a or Art. 1156 of the Swiss Code of Obligations, a listing prospectus in the sense of the SIX Swiss Exchange Listing Rules or a securities prospectus as defined in the German Securities Prospectus Act (Wertpapierprospektgesetz). Publication is for information purposes only and constitutes neither an offer to sell nor an invitation to buy or subscribe for securities. This media release and the information it contains must not be distributed or forwarded to or within the United States of America (USA) or to US persons (including legal entities) or publications with a general circulation in the USA. This media release does not constitute an offer or invitation to purchase any securities in the USA. The securities of HBM Healthcare Investments Ltd have not been registered under United States securities legislation and may not be offered, sold or delivered within the USA or to US persons without prior registration or the corresponding exemption from the registration requirements of US securities
legislation.
HBM Healthcare Investments AGBundesplatz 1 CH-6300 Zug | Tel: +41 41 768 11 08 | Fax: +41 41 768 11 09 | info@hbmhealthcare.com www.hbmhealthcare.com
|
distributed by
|
